CR8612A - DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS - Google Patents

DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS

Info

Publication number
CR8612A
CR8612A CR8612A CR8612A CR8612A CR 8612 A CR8612 A CR 8612A CR 8612 A CR8612 A CR 8612A CR 8612 A CR8612 A CR 8612A CR 8612 A CR8612 A CR 8612A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical compositions
dosage forms
formulations
dihydrobenzo
dioxin
Prior art date
Application number
CR8612A
Other languages
Spanish (es)
Inventor
Krishnendu Ghosh
Arwinder S Nagi
Xiaohong Pan
Melissa Lin
Leon Linberg
Ping Cai
Eric N Browne
Michael Bernatchez
Mark Lankau
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR8612A publication Critical patent/CR8612A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion proporciona, entre otras cosas, formulaciones que comprenden 4-ciano-N-{(2R)-2-[4-(2,3-dihidro- benzo[1,4]dioxin-5i1)-piperazin-1-il]-propil)-N-piridin-2-il-benzamida, sales farmaceuticamente aceptables de la misma, compuestos estructuralmente relacionados, y/o metabolitos; asi como el uso de estas formulaciones y metodos para el tratamiento de enfermedades.The present invention provides, among other things, formulations comprising 4-cyano-N - {(2R) -2- [4- (2,3-dihydrobenzo [1,4] dioxin-5i1) -piperazin-1- il] -propyl) -N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds, and / or metabolites; as well as the use of these formulations and methods for the treatment of diseases.

CR8612A 2004-03-19 2006-09-12 DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS CR8612A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55462204P 2004-03-19 2004-03-19

Publications (1)

Publication Number Publication Date
CR8612A true CR8612A (en) 2007-10-02

Family

ID=38063695

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8612A CR8612A (en) 2004-03-19 2006-09-12 DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS

Country Status (5)

Country Link
CN (1) CN1956977A (en)
CR (1) CR8612A (en)
PA (1) PA8626601A1 (en)
SV (1) SV2006002054A (en)
ZA (1) ZA200607803B (en)

Also Published As

Publication number Publication date
CN1956977A (en) 2007-05-02
ZA200607803B (en) 2009-09-30
SV2006002054A (en) 2006-02-15
PA8626601A1 (en) 2006-03-24

Similar Documents

Publication Publication Date Title
UY27740A1 (en) NEW COMPOUNDS
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
UY29562A1 (en) AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
MXPA05012573A (en) Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors.
GT200500098A (en) NEW COMPOUNDS
UY30460A1 (en) THERAPEUTIC COMPOUNDS
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
UY28026A1 (en) 4-PIPERAZINILBENCENOSULFONILINDOLES AND USES OF THE SAME.
PE20070541A1 (en) COMPOUNDS AND COMPOSITIONS INCLUDING ISOINDOL-IMIDES
PA8593101A1 (en) COMPOSITIONS FOR THE TREATMENT OF ABNORMAL CELL GROWTH
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
PA8587101A1 (en) NEW DERIVATIVES OF DIHYDROPIRIMIDO [4,5-D] PIRIMIDINONE REPLACED BY AMIINO, MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS
CL2004000732A1 (en) COMPOUNDS DERIVED FROM REPLACED OXIMES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND USE OF COMPOUNDS FOR THE TREATMENT OF CANCER.
CL2008001820A1 (en) Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
ECSP088967A (en) MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
GT200500309A (en) DERIVATIVES OF SULFONILBENCILIMIDAZOL
UY29561A1 (en) DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
BRPI0417714A (en) compound, pharmaceutical composition, and use of a compound
PA8568101A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
AR048336A1 (en) HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE
PA8514901A1 (en) METABOLITES AGONISTAS / ANTAGONISTAS DE ESTROGENO
ECSP066866A (en) DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS REFERENCE TO RELATED APPLICATIONS
AR047922A1 (en) NEW DERIVATIVES OF PENTAFLUORSULFANILO, ITS OBTAINING AND ITS USE AS PHARMACEUTICAL AGENTS
SE0401655D0 (en) New compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)